First human tests begin for potential new hives treatment pill
NCT ID NCT07230418
Summary
This is a very early, first-in-human study to check if a new oral drug called HRS-3095 is safe and how it behaves in the body. It involves healthy volunteers, not people with the condition it's intended for (chronic hives). The main goal is to understand the drug's safety profile, how it's absorbed, and if food affects it, before testing it in patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC SPONTANEOUS URTICARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Frist Clinical Medicial College of Qingdao University
RECRUITINGQingdao, Shandong, 266555, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.